EXO.AS stock trades at €67.90 after hours on 18 Mar 2026 as investors shift to an earnings preview ahead of Exor N.V.’s upcoming report. We focus on NAV, free cash flow and holdings valuation because Exor’s asset mix drives its share moves. The group has a market cap of €22,677,629,440 and trades below its 50-day average of €71.51. With the earnings date set for late March, this after-hours window matters for positioning and volatility into the report.
Earnings calendar and catalyst for EXO.AS stock
Exor N.V. confirms publication of financial statements in late March, making near-term catalysts clear. Investors should note the formal earnings announcement scheduled in the company calendar for 23 March 2026, which will include NAV commentary and cash receipts from recent disposals.
Expect commentary on capital allocation after recent asset sales and the notes offering. These items will determine whether the market re-rates Exor ahead of a likely busy deal pipeline.
Recent news and operational updates affecting EXO.AS stock
Recent headlines include the sale of Lifenet to Reale Mutua and Exor’s corporate calendar updates, which reduce execution risk but also reset cash expectations. See the company site for primary releases and the recent market writeups on Exor’s disposals for context source and market summary.
These transactions have raised cash but lower recurring earnings. That tradeoff is central to the earnings conversation and short-term price action.
Fundamentals and valuation snapshot for EXO.AS stock
Key fundamentals show mixed signals: EPS -2.99, PE -23.13 (negative due to losses), price to book 0.39, and book value per share €175.10. Exor carries low leverage with debt to equity 0.10 and a strong cash position: cash per share €7.38.
Valuation is shaped by large holdings in luxury and industrial names. The low PB ratio reflects a market discount to NAV rather than operating weakness in core assets. Dividend per share is €0.49, implying a yield near 0.71% at the current price.
Technical setup and trading signals for EXO.AS stock
Technicals show fatigue but not collapse. RSI is 37.10, MACD histogram negative, and Bollinger lower band sits near €67.95, close to today’s trade. Volume of 216,669 shares is below the 3-month average of 255,204, suggesting lower participation in the after-hours move.
Momentum indicators point to short-term oversold conditions. Traders should watch a break below €66.45 (year low) for confirmation of downside, or a recovery above the 50-day average €71.51 for a tactical rebound.
Meyka AI rates EXO.AS with a score out of 100 and forecast
Meyka AI rates EXO.AS with a score out of 100: 62.40, Grade B, suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects quarterly €63.84, yearly €55.80, and 3-year €21.48. Compared with the current price €67.90, the model implies a -5.98% move to the quarterly figure and -17.82% to the 12-month figure. Forecasts are model-based projections and not guarantees.
Risks and what to watch in the earnings report for EXO.AS stock
Earnings items to monitor: NAV reconciliation, realized gains from asset disposals, and planned use of proceeds from the recent €600 million notes. A weaker-than-expected NAV or lower dividend guidance could press the share price.
Countervailing opportunities include extra cash returned to shareholders or announcements of strategic investments. Watch management tone on M&A and Ferrari-related holdings for immediate price sensitivity.
Final Thoughts
Key takeaways for EXO.AS stock investors: Exor trades at €67.90 in EURONEXT after hours on 18 Mar 2026 with a market cap of €22.68 billion. The stock is defined by NAV dynamics and recent asset sales that boosted liquidity but may reduce recurring earnings. Financial metrics show PB 0.39 and negative EPS -2.99, while cash flow metrics and low leverage remain supportive. Meyka AI rates the stock 62.40/100 (B, HOLD) and issues model projections that point to a 12-month target of €55.80, implying -17.82% from today. For traders, the near-term technical levels to watch are €71.51 (50-day) and €66.45 (year low). For investors, the earnings release will clarify NAV drivers, cash deployment plans and potential shareholder returns. We recommend monitoring the published statements, management Q&A and the NAV bridge; use the earnings print to reset position size rather than chase volatility. See Exor documents and the company filing for primary detail source and our market page for real-time metrics Exor on Meyka.
FAQs
When does Exor publish earnings and how should I use that date for EXO.AS stock trades?
Exor’s calendar shows financial statements due in late March with an earnings announcement on 23 March 2026. Use the date to set risk limits: expect higher volatility two days before and after the print and watch NAV commentary for trade signals.
What valuation metrics matter most for EXO.AS stock?
For Exor, price-to-book and NAV are key because holdings drive value. Also monitor free cash flow per share (€13.54) and debt ratios; PB 0.39 signals a discount to reported book value.
How does Meyka AI view EXO.AS stock near earnings?
Meyka AI assigns a B (62.40) grade and models a 12-month €55.80 target. That implies downside versus today, so our model suggests caution and a focus on NAV updates and capital allocation in the earnings call.
What are the main risks after the earnings report for EXO.AS stock?
Risks include a weaker NAV reconciliation, reduced dividend guidance, or slower deployment of sale proceeds. Market reactions will hinge on clarity around investments and buyback or distribution plans.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)